In this penultimate episode of the video series that I recorded with ExchangeCME, I connect with Dr. Benjamin Scirica to explore the complex intersection of obesity and cardiovascular disease, with a focus on heart failure with preserved ejection fraction (HFpEF). Together, we examine the diagnostic challenges unique to patients with obesity, discuss the pathophysiologic drivers linking excess adiposity to cardiometabolic dysfunction, and review how glucagon-like peptide-1 (G

As the landscape of obesity treatment evolves, the intersection of pharmacologic therapies and surgical options becomes increasingly nuanced. In this episode, Dr. Janey Pratt and I explore when and how glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) can be used in relation to bariatric surgery. We discuss surgical candidacy criteria, benefits of bariatric surgery, long-term outcomes, and how to match treatment strategies to patient-specific characteristics, preference

Dr. Charles Vega and I collaborated on a 10-part educational video series focused on obesity management in the GLP-1 receptor agonist era. The series explores common clinical challenges encountered in primary care, with discussions led by leading experts in obesity medicine. I host several episodes and will be sharing them over the coming weeks. Episode 2 summary: Patients with obesity experience significant stigmas that often play a role in their decisions on how to manage t

Tomorrow I am concluding my Back To School Health Series with a discussion about Childhood Obesity, a topic I am truly passionate about....